Molecular Classification of Gastric Cancer With Emphasis on PDL-1 Expression: The First Report From Iran
Background: Gastric cancer is one of the lethal cancers and there is no effective treatment for these patients and still, 5-year survival rate is about 25% to 30%. Finding reliable biomarkers for early-stage diagnosis, targeted therapy, and survival prediction is a priority in this cancer. Objective...
Saved in:
Main Authors: | Fatemeh Amirmoezi (Author), Bita Geramizadeh (Author) |
---|---|
Format: | Book |
Published: |
SAGE Publishing,
2022-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluation of the Expression of Immunohistochemical Staining of PDL1 in Renal Cell Cancer
by: Rihab Mohammed Edress Al-Nuaimy, et al.
Published: (2024) -
Epidermal Growth Factor Receptor (EGFR) Gene Mutation Analysis in Adenocarcinoma of Lung, the First Report from Iran
by: Sahand Mohammadzadeh, et al.
Published: (2019) -
Effects of treatment with local anesthetics on RANKL expression in MG63 and PDL cells
by: Tsui-Hsein Huang, et al.
Published: (2021) -
Retroviral Replicating Vector Delivery of miR-PDL1 Inhibits Immune Checkpoint PDL1 and Enhances Immune Responses In Vitro
by: Amy H. Lin, et al.
Published: (2017) -
P16 and P53 Expression in Esophageal Squamous Cell Carcinoma: A Brief Report From The Experience of South of Iran, and Review of the Literature
by: Bita Geramizadeh, et al.
Published: (2021)